# Impact Of The Gut Microbiota On Host Cells Energy Metabolism in Health And In Inflammatory Bowel Disease

> **NCT07300553** · PHASE2 · RECRUITING · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 45 (estimated)

## Conditions studied

- IBD
- Crohn Disease
- Ulcerative Colitis (UC)

## Interventions

- **DRUG:** Vancomycin /Amphotericin B (Fungizone®) /Gentamicine 80 mg
- **DIETARY_SUPPLEMENT:** Inulin/Inulin C13

## Key facts

- **NCT ID:** NCT07300553
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-01-02
- **Primary completion:** 2026-11
- **Final completion:** 2027-08
- **Target enrollment:** 45 (ESTIMATED)
- **Last updated:** 2026-03-12

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07300553

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07300553, "Impact Of The Gut Microbiota On Host Cells Energy Metabolism in Health And In Inflammatory Bowel Disease". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT07300553. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*